Advertisement
Screener

PANDION THERAPEUTICS, INC. Operating Cash Flow

PANDION THERAPEUTICS, INC. Operating Cash Flow

PANDION THERAPEUTICS, INC. reported Operating Cash Flow of -$34.99 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-03-12

  • PANDION THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$11.17M, a 487.47% decline year-over-year.
  • PANDION THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was -$9.73M.
  • PANDION THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was $2.88M.
  • PANDION THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$4.69M.
  • PANDION THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$34.99M.
  • PANDION THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$13.43M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2020-12-31-$11.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$20.90M
derived: sum of 2 quarters · filed 2021-03-12
-$34.99M
10-K · filed 2021-03-12
2020-09-30-$9.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
-$23.82M
10-Q · filed 2020-11-16
2020-06-30-$14.09M
10-Q · filed 2020-08-31
2019-12-31$2.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$1.81M
derived: sum of 2 quarters · filed 2021-03-12
-$13.43M
10-K · filed 2021-03-12
2019-09-30-$4.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
-$16.31M
10-Q · filed 2020-11-16
2019-06-30-$11.62M
10-Q · filed 2020-08-31